Endogenous defense mechanism-based neuroprotection in large-vessel acute ischemic stroke: A hope for future

Endogenous defense mechanism-based neuroprotection in large-vessel acute ischemic stroke: A hope for future

BACKGROUND: Stroke is a leading cause of morbidity and mortality worldwide and a leading cause of disability. None of the neuroprotective agents have been approved internationally except edaravone in Japanese guidelines in acute ischemic stroke. We here discuss that there are two types of endogenous...

Full description

Bibliographic Details
Main Authors: Deepak Goel, Sushant Shangari, Manish Mittal, Ashwani Bhat
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Brain Circulation
Subjects:
endogenous stroke neuroprotection
multimodal neuroprotection therapy
vinpocetine in stroke
Online Access:http://www.braincirculation.org/article.asp?issn=2394-8108;year=2024;volume=10;issue=1;spage=51;epage=59;aulast=Goel

Internet

http://www.braincirculation.org/article.asp?issn=2394-8108;year=2024;volume=10;issue=1;spage=51;epage=59;aulast=Goel

Similar Items